Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition. [PDF]
Int J Mol SciPamfil C +6 more
europepmc +1 more source
Upadacitinib for Immune Checkpoint Inhibitor-Related Dermatitis: A Nonrandomized Clinical Trial.
JAMA OncolChen C +7 more
europepmc +1 more source
Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. [PDF]
CureusAhmad F +5 more
europepmc +1 more source
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study [PDF]
Casale Alloa, Marta +6 more
core +1 more source
A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence. [PDF]
Am J Case RepAlhashemi M, Shehab M.
europepmc +1 more source
Leukocytoclastic Vasculitis Occurring During Upadacitinib Therapy in Ulcerative Colitis: A Case Report. [PDF]
Turk J GastroenterolGünegül Y +4 more
europepmc +1 more source
Upadacitinib for recalcitrant extraintestinal Crohn disease. [PDF]
JAAD Case RepSeward AH, Callen JP.
europepmc +1 more source
Successful treatment of poison ivy dermatitis with upadacitinib. [PDF]
JAAD Case RepTai H +4 more
europepmc +1 more source
Prospective Bi-Centric Real-World Outcomes of Upadacitinib in Biologic-Experienced Patients with Crohn's Disease. [PDF]
DiseasesLüke J +10 more
europepmc +1 more source